BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36416305)

  • 21. APOBEC3B lysine residues are dispensable for DNA cytosine deamination, HIV-1 restriction, and nuclear localization.
    Molan AM; Hanson HM; Chweya CM; Anderson BD; Starrett GJ; Richards CM; Harris RS
    Virology; 2017 Nov; 511():74-81. PubMed ID: 28841445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural Characterization of a Minimal Antibody against Human APOBEC3B.
    Tang H; Demir Ö; Kurniawan F; Brown WL; Shi K; Moeller NH; Carpenter MA; Belica C; Orellana K; Du G; LeBeau AM; Amaro RE; Harris RS; Aihara H
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33921405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA cytosine and methylcytosine deamination by APOBEC3B: enhancing methylcytosine deamination by engineering APOBEC3B.
    Fu Y; Ito F; Zhang G; Fernandez B; Yang H; Chen XS
    Biochem J; 2015 Oct; 471(1):25-35. PubMed ID: 26195824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BRAF, NRAS, KIT, TERT, GNAQ/GNA11 mutation profile analysis of head and neck mucosal melanomas: a study of 42 cases.
    Öztürk Sari Ş; Yilmaz İ; Taşkin OÇ; Narli G; Şen F; Çomoğlu Ş; Firat P; Bİlgİç B; Yilmazbayhan D; Özlük Y; Büyükbabanİ N
    Pathology; 2017 Jan; 49(1):55-61. PubMed ID: 27914687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOBEC3B reporter myeloma cell lines identify DNA damage response pathways leading to APOBEC3B expression.
    Yamazaki H; Shirakawa K; Matsumoto T; Kazuma Y; Matsui H; Horisawa Y; Stanford E; Sarca AD; Shirakawa R; Shindo K; Takaori-Kondo A
    PLoS One; 2020; 15(1):e0223463. PubMed ID: 31914134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural Analysis of the Active Site and DNA Binding of Human Cytidine Deaminase APOBEC3B.
    Hou S; Silvas TV; Leidner F; Nalivaika EA; Matsuo H; Kurt Yilmaz N; Schiffer CA
    J Chem Theory Comput; 2019 Jan; 15(1):637-647. PubMed ID: 30457868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APOBEC3B coordinates R-loop to promote replication stress and sensitize cancer cells to ATR/Chk1 inhibitors.
    Zong C; Zhang Z; Gao L; He J; Wang Y; Li Q; Liu X; Yang J; Chen D; Huang R; Zheng G; Jin X; Wei W; Jia R; Shen J
    Cell Death Dis; 2023 Jun; 14(6):348. PubMed ID: 37270643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed activation of NF-κB.
    Periyasamy M; Singh AK; Gemma C; Farzan R; Allsopp RC; Shaw JA; Charmsaz S; Young LS; Cunnea P; Coombes RC; Győrffy B; Buluwela L; Ali S
    Oncogene; 2021 Feb; 40(6):1077-1090. PubMed ID: 33323971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying germline APOBEC3B deletion and immune phenotype in Korean patients with operable breast cancer.
    Kim SH; Ahn S; Suh KJ; Kim YJ; Park SY; Kang E; Kim EK; Kim IA; Chae S; Choi M; Kim JH
    Breast Cancer Res Treat; 2020 Oct; 183(3):697-704. PubMed ID: 32715441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits.
    Cheng AZ; Moraes SN; Attarian C; Yockteng-Melgar J; Jarvis MC; Biolatti M; Galitska G; Dell'Oste V; Frappier L; Bierle CJ; Rice SA; Harris RS
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Rabbit Monoclonal Antibody against the Antiviral and Cancer Genomic DNA Mutating Enzyme APOBEC3B.
    Brown WL; Law EK; Argyris PP; Carpenter MA; Levin-Klein R; Ranum AN; Molan AM; Forster CL; Anderson BD; Lackey L; Harris RS
    Antibodies (Basel); 2019 Sep; 8(3):. PubMed ID: 31544853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformational Switch Regulates the DNA Cytosine Deaminase Activity of Human APOBEC3B.
    Shi K; Demir Ö; Carpenter MA; Wagner J; Kurahashi K; Harris RS; Amaro RE; Aihara H
    Sci Rep; 2017 Dec; 7(1):17415. PubMed ID: 29234087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication.
    Bonvin M; Achermann F; Greeve I; Stroka D; Keogh A; Inderbitzin D; Candinas D; Sommer P; Wain-Hobson S; Vartanian JP; Greeve J
    Hepatology; 2006 Jun; 43(6):1364-74. PubMed ID: 16729314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for APOBEC3B mRNA and protein expression in oral squamous cell carcinomas.
    Fanourakis G; Tosios K; Papanikolaou N; Chatzistamou I; Xydous M; Tseleni-Balafouta S; Sklavounou A; Voutsinas GE; Vastardis H
    Exp Mol Pathol; 2016 Dec; 101(3):314-319. PubMed ID: 27818121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural determinants of APOBEC3B non-catalytic domain for molecular assembly and catalytic regulation.
    Xiao X; Yang H; Arutiunian V; Fang Y; Besse G; Morimoto C; Zirkle B; Chen XS
    Nucleic Acids Res; 2017 Jul; 45(12):7494-7506. PubMed ID: 28575276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer.
    Carpenter MA; Temiz NA; Ibrahim MA; Jarvis MC; Brown MR; Argyris PP; Brown WL; Starrett GJ; Yee D; Harris RS
    PLoS Genet; 2023 Nov; 19(11):e1011043. PubMed ID: 38033156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.
    Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Kurlander R; Patterson AP
    J Biol Chem; 2017 Aug; 292(32):13459-13479. PubMed ID: 28637869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KIT, NRAS and BRAF mutations in sinonasal mucosal melanoma: a study of 56 cases.
    Zebary A; Jangard M; Omholt K; Ragnarsson-Olding B; Hansson J
    Br J Cancer; 2013 Aug; 109(3):559-64. PubMed ID: 23860532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOBEC3B can impair genomic stability by inducing base substitutions in genomic DNA in human cells.
    Shinohara M; Io K; Shindo K; Matsui M; Sakamoto T; Tada K; Kobayashi M; Kadowaki N; Takaori-Kondo A
    Sci Rep; 2012; 2():806. PubMed ID: 23150777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity.
    Byeon IJ; Byeon CH; Wu T; Mitra M; Singer D; Levin JG; Gronenborn AM
    Biochemistry; 2016 May; 55(21):2944-59. PubMed ID: 27163633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.